Skip to content

CareDx CDNA Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Natera, Inc. logo
Natera, Inc.NTRA
NeoGenomics logo
NeoGenomicsNEO
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Veracyte logo
VeracyteVCYT
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's accrued manufacturing costs?
CareDx (CDNA) reported accrued manufacturing costs of $20.55M in Q1 2026.
How has CareDx's accrued manufacturing costs changed year-over-year?
CareDx's accrued manufacturing costs increased by 46.1% year-over-year, from $14.07M to $20.55M.
What is the long-term trend for CareDx's accrued manufacturing costs?
Over 5 years (2020 to 2025), CareDx's accrued manufacturing costs has grown at a 15.6% compound annual growth rate (CAGR), from $18.47M to $38.11M.